|
|
Article: CorAssist Raises $5.25 Million In Private Financing.
- Article from:
- Heart Disease Weekly
- Article date:
- April 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CorAssist Cardiovascular Ltd., a developer of novel therapeutic devices for Diastolic Heart Failure (DHF), announced that it has raised $5.25 million in a private financing led by Aurum Ventures MKI. The round was joined by previous investors Ofer Hi-Tech Group, Yozma Management, Evergreen Venture Partners and Argonaut Ventures (see also Heart Failure).
"We have made significant progress with the ImCardia™, as well as with our minimally invasive devices, the ImCardia-MIS and the CORrolla," said Amir Loshakove, CEO of CorAssist. "This additional capital enables us to continue the execution of our strategy of leadership in therapeutic devices for DHF."
...